Title	Publication Date	Language	Citations
Vitamin D and Multiple Sclerosis: A Comprehensive Review	2017/12/14	English	214
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood	2017/07/01	English	171
Mechanism of Action and Clinical Application of Tafamidis in Hereditary Transthyretin Amyloidosis	2016/02/19	English	114
Alzheimer’s Disease: Epidemiology and Clinical Progression	2022/03/14	English	108
Fingolimod Rebound: A Review of the Clinical Experience and Management Considerations	2019/11/01	English	91
A Review of Patisiran (ONPATTRO®) for the Treatment of Polyneuropathy in People with Hereditary Transthyretin Amyloidosis	2020/08/12	English	91
An Update on Blood-Based Markers of Alzheimer’s Disease Using the SiMoA Platform	2019/12/01	English	79
Pregnancy Outcomes Following Maternal and Paternal Exposure to Teriflunomide During Treatment for Relapsing–Remitting Multiple Sclerosis	2014/11/20	English	79
Amyloid Beta and Tau as Alzheimer’s Disease Blood Biomarkers: Promise From New Technologies	2017/07/01	English	79
The Impact of Red Blood Cell Distribution Width and Neutrophil/Lymphocyte Ratio on the Diagnosis of Major Depressive Disorder	2015/12/19	English	69
Antipsychotic-Related Movement Disorders: Drug-Induced Parkinsonism vs. Tardive Dyskinesia—Key Differences in Pathophysiology and Clinical Management	2018/07/19	English	65
Deep Learning and Neurology: A Systematic Review	2019/08/21	English	63
Comparative Effectiveness Research of Disease-Modifying Therapies for the Management of Multiple Sclerosis: Analysis of a Large Health Insurance Claims Database	2017/02/16	English	61
Delayed-Release Dimethyl Fumarate and Pregnancy: Preclinical Studies and Pregnancy Outcomes from Clinical Trials and Postmarketing Experience	2015/10/12	English	60
A Systematic Review and Meta-Analysis of the Brief Cognitive Assessment for Multiple Sclerosis (BICAMS)	2018/06/19	English	59
Diagnosing and Treating Depression in Patients with Alzheimer’s Disease	2019/08/21	English	58
Transthyretin Amyloidosis: Update on the Clinical Spectrum, Pathogenesis, and Disease-Modifying Therapies	2020/09/18	English	56
A Review of Tafamidis for the Treatment of Transthyretin-Related Amyloidosis	2015/08/15	English	56
Detection of Plasma Biomarkers Using Immunomagnetic Reduction: A Promising Method for the Early Diagnosis of Alzheimer’s Disease	2017/07/01	English	56
Neurophysiological Markers of Alzheimer’s Disease: Quantitative EEG Approach	2019/12/01	English	52
Virtual Reality Versus Conventional Treatment of Reaching Ability in Chronic Stroke: Clinical Feasibility Study	2012/08/24	English	50
Characterizing the High Disease Burden of Transthyretin Amyloidosis for Patients and Caregivers	2018/08/02	English	49
Comprehensive Approach to Management of Multiple Sclerosis: Addressing Invisible Symptoms—A Narrative Review	2021/04/20	English	49
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders	2019/12/01	English	48
Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate	2018/01/24	English	48
Depression Among HIV/AIDS Patients on Highly Active Antiretroviral Therapy in the Southwest Regional Hospitals of Cameroon: A Cross-Sectional Study	2017/03/18	English	45
A Narrative Review of the Role of Transthyretin in Health and Disease	2020/10/01	English	42
Increasing Precision of Clinical Diagnosis of Alzheimer's Disease Using a Combined Algorithm Incorporating Clinical and Novel Biomarker Data	2017/07/01	English	42
European and American Guidelines for Multiple Sclerosis Treatment	2018/10/12	English	41
Pathophysiology of Chronic Inflammatory Demyelinating Polyneuropathy: Insights into Classification and Therapeutic Strategy	2020/05/14	English	40